Trend

QS Research · Michael Burry's Scion Capital analyst template · 2006

Cboe Global Markets, Inc. (CBOE)

As of 2026-11-21 · 12/15 boxes filled from SEC filings and market data

Report price $357.71 (close 2026-11-20)

Conclusion: PASS

Conviction low · base case -2% · downside -24% · upside +12%

The market is already paying for Cboe's quality: at $357.71 the stock carries 25.3x TTM net income to common of $1.47B, while 7.07x TTM sales sits above the 3.4x-5.6x five-year range. Cash conversion is strong and the franchise is licensed rather than easily replicated, but the price reflects that, and the only independent anchor available is a three-peer median, so conviction is limited. The downside case is -23.5% to $273.65 on a 10.0% earnings cut at a compressed P/E of 21.5x (today 25.3x). The base case is -1.6% to $352.05 on P/E at 24.9x, the peer median P/E across NDAQ 27.7x, ICE 22.9x and CME 24.9x. The upside case is +12.0% to $400.64 on +12% earnings at today's P/E of 25.3x. That spread does not offer an edge, so the call is PASS.

Key numbers

  • Share price: $357.71
  • Market cap: $37.32B
  • Latest financial period: TTM to Sep 30, 2026
  • Revenue (TTM): $5.28B
  • P/E (TTM): 25.3x
  • Price / book: 6.30x
  • Earnings-quality flags (TTM): none flagged
  • Revenue growth (latest fiscal year): +15.1%

The 15 boxes

  1. ✓ 1. Long-form business notes

    Cboe Global Markets, Inc. (formerly CBOE Holdings, Inc. until 2017-10-13) is an exchange network earning transaction/clearing fees, market-data and access fees, index licensing and listings across options, North American equities, Europe/Asia Pacific, futures and global FX. FY2025 revenue was $4.71B with GAAP operating income of $1.47B and net income to common of $1.09B; the TTM to 2026-09-30 base is $5.28B revenue and $1.92B operating income, so valuation should sit on the current post-2025 portfolio, not the FY2020 base. Between the FY2020 and FY2025 10-Ks the segment set changed, with European Equities becoming Europe and Asia Pacific and Digital folded into Futures, while management wound down Japan, moved Australia/Canada to sale, exited corporate listings and cut ETP/CEDX/analytics costs.

  2. ✓ 2. Competitive advantage

    The advantage is a licence and scale moat, not a cost moat: in 2025 about 68% of revenues less cost of revenues came from the options and futures segments, mostly products on exclusively licensed indices (SPX) and the proprietary VIX methodology, and revenue is 74% transaction- and clearing-based. The numbers bear that out: gross profit rose from $1.25B (FY2020) to $2.43B (FY2025) and $2.84B (TTM to Sep 2026), operating income from $662.2M to $1.47B and $1.92B, a roughly 36% TTM operating margin, on net income to common of $1.47B TTM against $5.93B total equity. Competition is severe and price-driven: as of December 31, 2025 four Cboe options exchanges face 14 other U.S. options exchanges (two more expected in the first half of 2026), and multi-listed options pricing has historically compressed net revenue per contract. The moat's weak point is contractual — the exclusive index and VIX licences can be lost or non-renewed.

  3. ✓ 3. 10-Q takeaways

    Q3 2026 net revenue rose 18% to $712.2 million and organic net revenue rose 19% to $709.3 million, with increases in all revenue categories and Options net revenue up 23%. GAAP operating margin was 75.0%, but it included a $71.5 million Cboe Australia divestiture gain; adjusted operating margin was 71.4% and adjusted operating expenses fell to $204.0 million. Management raised 2026 organic revenue growth targets and cut adjusted operating expense guidance to $830-$845 million. The 10-Q reports no material risk-factor updates.

  4. ✓ 4. Corporate governance

    Filled; members read this box.

  5. ✓ 5. Overview of the prior 3 years of 8-K filings

    Filled; members read this box.

  6. ✓ 6. Other significant filings

    Filled; members read this box.

  7. ✓ 7. Chronology of significant news and events

    Filled; members read this box.

  8. ✓ 8. Comparables valuation interpretation

    Filled; members read this box.

  9. ✓ 9. Insider trading interpretation

    Filled; members read this box.

  10. ○ 10. Earnings-call notes
  11. ○ 11. Impression of the shareholder letter
  12. ○ 12. Scuttlebutt overview
  13. ✓ 13. Valuation and risk/reward summary

    Filled; members read this box.

  14. ✓ 14. Current price suppression and potential catalysts

    Filled; members read this box.

  15. ✓ 15. Conclusions

    The call above.

Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.

Put these signals to work

The Scion template's preview is free. Paid members read every box of every report. FST, the QuantSignals trading agent, uses QS Research as its brain.

Join freeMeet FSTSee plans